| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1071827B1 Mixed cell diagnostic systems |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/21/2007 | EP0870014B1 Aldolase catalytic antibody |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0602046B2 Detection of feline immunodeficiency viruses |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918298A Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 02/21/2007 | CN1918297A A novel hansenula polymorpha gene coding for alpha 1,6-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same |
| 02/21/2007 | CN1918296A Toxin complex proteins and genes from xenorhabus bovienii |
| 02/21/2007 | CN1918295A Method of reinforcing antibody activity |
| 02/21/2007 | CN1918282A Lactic acid bacteria producing nisin at high concentration and method for selecting the same |
| 02/21/2007 | CN1916181A Functional mixed short peptide of peanut, and prepartion method |
| 02/21/2007 | CN1916175A Method for recombining dog CaIFN-alpha in production of silkworm |
| 02/21/2007 | CN1916022A Gene correlative to cardiovascular pathology caused by diabetes, and usage |
| 02/21/2007 | CN1916017A Process for producing hydrophobic polypeptides, proteins or peptides. |
| 02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
| 02/21/2007 | CN1301332C Preparation of amino acid polypeptide composite liquid from forest frog muscle |
| 02/21/2007 | CN1301264C Oxidation resistant bioactive peptide of halobios and preparation method |
| 02/20/2007 | US7179961 Transforming plant tissues having germ cells with nucleotide sequences, then culturing and harvesting the grains such that the cells have increased biomass; genetic engineering |
| 02/20/2007 | US7179904 Useful for modulating transcription of a desired polynucleotide |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179886 Transfecting test cells with an expression vector encoding motilin receptor; exposing test cells to a ligand; measuring amount of binding of the ligand to the motilin receptor; comparing with amount of binding of the ligand to control cells that have not been transfected with the motilin receptor |
| 02/20/2007 | US7179884 Polypeptides; proteolysis splitting; antitumor agents |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179790 Brain natriuretic peptide |
| 02/20/2007 | US7179635 Peptides for use in culture media |
| 02/20/2007 | US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179626 Changing the amino acid at position 576 of SEQ ID NO: 3 to a Phe residue, whereupon the specificity of the potato tuber lipoxygenase for position 11 of arachidonic acid is enhanced |
| 02/20/2007 | US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene |
| 02/20/2007 | US7179619 Methods and compositions for inhibiting herpesviral replication |
| 02/20/2007 | US7179618 Streptavidin proteins |
| 02/20/2007 | US7179617 Forming a convalent conjugate of a Factor IX peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 02/20/2007 | US7179611 Purification; isoelectric precipitation; analyzing |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179606 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179605 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179601 Methods of identifying plant disease-resistance genes |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179464 Immunoglobulin for use in the treatment and prevention of asthma |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2192512C Nm03 antibody materials and methods |
| 02/20/2007 | CA2175628C Production of recombinant factor viii in the presence of liposome-like substances of mixed composition |
| 02/15/2007 | WO2007018879A2 Interferon-gamma antagonists and therapeutic uses thereof |
| 02/15/2007 | WO2007018853A2 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | WO2007018315A1 Protein probe for use in detection of interaction between the protein and other molecule |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2007017637A1 Method for producing recombinant interferon alpha-8 |
| 02/15/2007 | WO2007016861A1 Two-steps enzyme method for preparing 7-aminocephalosporanic acid |
| 02/15/2007 | WO2007016860A1 Escherichia coli expression vector and the uses thereof |
| 02/15/2007 | WO2006127860A3 Multiplex method for increased proteomic coverage from histopathologically processed biological samples using liquid tissue preparations |
| 02/15/2007 | WO2006078821A3 Products and processes for in vitro synthesis of biomolecules |
| 02/15/2007 | WO2006031992A3 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes |
| 02/15/2007 | WO2006011151A3 Vaccine comprising recombinant ct or lt toxin |
| 02/15/2007 | WO2005003289A8 Ap1 amine oxidase variants |
| 02/15/2007 | WO2003099854A3 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| 02/15/2007 | US20070037965 Fusion proteins; human cytokine receptors; usefulness in both basic research and as therapeutics |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037736 Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury |
| 02/15/2007 | US20070037258 Methods and compositions for enhancing protein folding |
| 02/15/2007 | US20070037256 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/15/2007 | US20070037255 Antibody variants with faster antigen association rates |
| 02/15/2007 | US20070037254 Expression Vectors and Methods |
| 02/15/2007 | US20070037253 18-Residue dimerized peptide designated PIP [59-67] dimer, having dual inhibitory activity against secretory phospholipase A2 (sPLA2) and matrix metalloproteinases (MMPs); acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity |
| 02/15/2007 | US20070037252 Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 02/15/2007 | US20070037251 Novel protein expression system |
| 02/15/2007 | US20070037250 Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 02/15/2007 | US20070037249 Molecules that block viral infectivity and methods of use thereof |
| 02/15/2007 | US20070037248 Production of modified glycoproteins having multiple antennary structures |
| 02/15/2007 | US20070037247 Polypeptide having a thermostable ribonuclease H activity; highly valuable for genetic engineering |
| 02/15/2007 | US20070037246 Methods and compositions for enhanced protein expression and purification |
| 02/15/2007 | US20070037245 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 02/15/2007 | US20070037243 Process for producing alpha-glycosylated dipeptide and method of assaying alpha-glycosylated dipeptide |
| 02/15/2007 | US20070037242 Exposing biopolymer to digestion agent irreversibly immobilized on exterior surface of the wall to cleave the biopolymer into fragments; permitting the fragments to permeate through the wall of the hollow element from exterior surface to interior region |
| 02/15/2007 | US20070037233 Detection of Preharvest Sprouting in Cereal Grains |
| 02/15/2007 | US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 02/15/2007 | US20070037211 Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of mycobacterium tuberculosis |
| 02/15/2007 | US20070037204 protein encoded by the nucleotide sequence represented by SEQ ID NO: 1 to 65 ; useful for diagnosing and treating cancer |
| 02/15/2007 | US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
| 02/15/2007 | US20070037193 Modulation of peroxisome proliferator-activated receptors |
| 02/15/2007 | US20070037192 Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile |
| 02/15/2007 | US20070037191 Apo-2DcR |
| 02/15/2007 | US20070037188 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases; contacting a target cell with a test compound, measuring the levels of reporter gene transcription that occurs in the presence and absence of the test compound; comparing the levels of reporter gene transcription |
| 02/15/2007 | US20070037178 Endocrine cell lines and method of using the same |
| 02/15/2007 | US20070037161 Motoneuronotrophic factor gene sequences |
| 02/15/2007 | US20070037160 Method for the dissociation of the extracellular haemoglobin molecule of <I> arenicola marina </I> and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 02/15/2007 | US20070037159 Tetrahydrofolate synthetase gene |
| 02/15/2007 | US20070037149 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070036883 Plant-derived alkaline alpha-galactosidase |